Campbell & Co Investment Adviser’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,946	Closed	-$1.42M	–	1187
2023 Q1	$1.42M	Buy	+39,946	New	+$1.45M	0.27%	74
2022 Q4	–	Sell	-43,746	Closed	-$2.06M	–	1057
2022 Q3	$2.06M	Buy	43,746 +37,550	+606%	+$2.43M	0.47%	22
2022 Q2	$444K	Buy	+6,196	New	+$453K	0.12%	316
2021 Q4	–	Sell	-5,050	Closed	-$442K	–	873
2021 Q3	$442K	Buy	5,050 +2,800	+124%	+$253K	0.14%	251
2021 Q2	$201K	Sell	2,250 -4,696	-68%	-$397K	0.08%	454
2021 Q1	$527K	Buy	6,946 +1,819	+35%	+$137K	0.32%	93
2020 Q4	$349K	Buy	+5,127	New	+$320K	0.21%	185
2020 Q1	–	Sell	-6,300	Closed	-$375K	–	574
2019 Q4	$375K	Sell	6,300 -5,671	-47%	-$305K	0.12%	334
2019 Q3	$637K	Buy	11,971 +5,539	+86%	+$284K	0.24%	111
2019 Q2	$329K	Sell	6,432 -1,869	-23%	-$87K	0.15%	277
2019 Q1	$430K	Buy	8,301 +582	+8%	+$28.2K	0.21%	162
2018 Q4	$336K	Buy	7,719 +2,019	+35%	+$93.8K	0.33%	122
2018 Q3	$294K	Buy	+5,700	New	+$279K	0.2%	227

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Campbell & Co Investment Adviser's SYNH Position: Q2 2023 in Review

Campbell & Co Investment Adviser sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 39,946 shares — an estimated $1.42M sold.

Campbell & Co Investment Adviser first reported a position in SYNH in Q3 2018 and held it in 13 quarters. The position peaked at $2.06M in Q3 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Campbell & Co Investment Adviser reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 39,946 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.42M.
Campbell & Co Investment Adviser first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 13 quarters.
Campbell & Co Investment Adviser's Syneos Health, Inc. Class A Common Stock position peaked at $2.06M in Q3 2022.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2023, filed 11 Aug 2023.